Company intelligence / Profile preview

VDI Technologies

Ownership: Private
Development stage: Commercial

Overview

VDI Technologies has developed and commercialized advanced cardiac diagnostic devices using ultra-high frequency ECG mapping. Their products are CE marked, indicating regulatory approval for clinical use in Europe. The company continues to innovate with new research tools such as Real-Time VDI DeepView. Clinical results are not detailed publicly but the company is active at major cardiology conferences.

Therapeutic areas: Cardiovascular
Modalities: DeviceDiagnostic technology (UHF-ECG Mapping)
Industry: Physiological Monitoring

Beyond the preview

Go deeper on VDI Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VDI Technologies.

Explore the full profile